Skip to content

Author

Dario Trapani

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Treatment Effect Discrepancy Between PFS and OS in Antibody-Drug Conjugate Trials for Metastatic Breast Cancer: A Meta-Epidemiologic Analysis.

OBJECTIVE The validity of progression-free survival (PFS) as a surrogate for overall survival (OS) in the antibody-drug conjugate (ADCs) era remains uncertain. We evaluated the association between treatment effects on PFS and OS in randomized trials of ADCs for metastatic breast cancer (mBC) and explored the surrogate...

L. F. Costa de Almeida, A. Cappellaro, M. Noronha et al. · 0 citations
Open access Sep 2026

Global uptake of essential cancer medicines with and without complex genomic diagnostics: a retrospective observational study.

BACKGROUND New cancer medicines increasingly depend on molecular testing, from low-cost immunohistochemistry to expensive genomic diagnostics. The WHO Model List of Essential Medicines (EML) guides access to priority medicines. We aimed to analyse uptake trends for essential cancer medicines in 71 countries and two wor...

Kerstin N. Vokinger, S. Hediger, R. Casolino et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.